Research output per year
Research output per year
Fingerprint
Dive into the research topics where Varda Shoshan-Barmatz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
Verma, A., Pittala, S., Alhozeel, B., Shteinfer-Kuzmine, A., Ohana, E., Gupta, R., Chung, J. H. & Shoshan-Barmatz, V., 2 Feb 2022, In: Molecular Therapy. 30, 2, p. 726-744 19 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Shoshan-Barmatz, V., Anand, U., Nahon-Crystal, E., Di Carlo, M. & Shteinfer-Kuzmine, A., 4 Oct 2021, In: Frontiers in Physiology. 12, 730048.Research output: Contribution to journal › Review article › peer-review
Open Access13 Scopus citations -
Novel piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction
Shoshan-Barmatz, V. & Lev Gruzman, A., 25 Feb 2021, IPC No. C07D 403/ 04 A I, Patent No. AU2021200421, Priority date 22 Jan 2021, Priority No. AU20210200421Research output: Patent
-
NOVEL PIPERAZINE AND PIPERIDINE DERIVATIVES, THEIR SYNTHESIS AND USE THEREOF IN INHIBITING VDAC OLIGOMERIZATION, APOPTOSIS AND MITOCHONDRIA DYSFUNCTION
Shoshan-Barmatz, V. & Lev Gruzman, A., 11 Feb 2021, IPC No. C07D 491/ 04 A I, Patent No. US2021040047, Priority date 6 Aug 2020, Priority No. US202016947557Research output: Patent
-
SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
Pandey, S. K., Paul, A., Shteinfer-Kuzmine, A., Zalk, R., Bunz, U. & Shoshan-Barmatz, V., 1 Nov 2021, In: Molecular Oncology. 15, 11, p. 3037-3061 25 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Vdac1 silencing in cancer cells leads to metabolic reprogramming that modulates tumor microenvironment
Zerbib, E., Arif, T., Shteinfer-Kuzmine, A., Chalifa-Caspi, V. & Shoshan-Barmatz, V., 1 Jun 2021, In: Cancers. 13, 11, 2850.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
BIOMARKERS FOR DIAGNOSIS OF LUNG CANCER
Shoshan-Barmatz, V., 4 Jun 2020, IPC No. G01N 33/ 68 A I, Patent No. US2020173998, Priority date 22 May 2018, Priority No. US201816615147Research output: Patent
-
BIOMARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USE THEREOF
Shoshan-Barmatz, V., 27 Aug 2020, IPC No. G01N 33/ 49 A I, Patent No. US2020270701, Priority date 19 Dec 2016, Priority No. US201616063784Research output: Patent
-
Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS
Leyton-Jaimes, M. F., Ivert, P., Hoeber, J., Han, Y., Feiler, A., Zhou, C., Pankratova, S., Shoshan-Barmatz, V., Israelson, A. & Kozlova, E. N., 1 Dec 2020, In: Scientific Reports. 10, 1, 20675.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
EMPTY POROUS PARTICLES FOR USE IN TREATMENT, PREVENTION AND/OR POSTPONEMENT OF DEGENERATION OF NEURODEGENERATIVE DISEASES, NEURONS AND GLIA.
Feiler, A., Kozlova, E., Zhou, C., Israelson, A. & Shoshan-Barmatz, V., 22 Oct 2020, IPC No. G01N 33/ 68 A I, Patent No. WO2020212418, Priority date 15 Apr 2019, Priority No. SE20190050470Research output: Patent
Press / Media
-
Making the desert bloom with biotechnology
Varda Shoshan-Barmatz, Ran Zalk, Tomer Hertz & Ohad Birk
7/06/19
1 item of Media coverage
Press/Media